- Home
- ABEO vs PINE Comparison
ABEO vs PINE Comparison
Compare ABEO & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEO | PINE |
|---|---|---|
| Founded | 1974 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.2M | 287.3M |
| IPO Year | 2005 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ABEO | PINE |
|---|---|---|
| Price | $4.80 | $18.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $20.00 | ★ $20.10 |
| AVG Volume (30 Days) | ★ 1.4M | 135.8K |
| Earning Date | 05-14-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 6.62% |
| EPS Growth | ★ 165.16 | N/A |
| EPS | ★ 1.01 | N/A |
| Revenue | $2,998,000.00 | ★ $60,532,000.00 |
| Revenue This Year | $1,276.65 | $18.03 |
| Revenue Next Year | $112.53 | N/A |
| P/E Ratio | $4.77 | ★ N/A |
| Revenue Growth | ★ 258.18 | 15.90 |
| 52 Week Low | $3.93 | $13.10 |
| 52 Week High | $7.54 | $20.80 |
Technical Indicators
Market Signals| Indicator | ABEO | PINE |
|---|---|---|
| Relative Strength Index (RSI) | 54.01 | 44.91 |
| Support Level | $4.53 | $16.47 |
| Resistance Level | $5.62 | $20.80 |
| Average True Range (ATR) | 0.20 | 0.48 |
| MACD | 0.03 | -0.06 |
| Stochastic Oscillator | 76.62 | 32.22 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.